In endometrial cancer, PRMT3 interacts with the Arg418 residue of METTL14 and enhances METTL14’s m6A catalytic activity via methylation, thereby regulating ferroptosis-related genes (17). This evidence concerns the gene PRMT3 and endometrial cancer.